Events & News


Meeting at MEDICA 2020 in Düsseldorf discuss cooperation possibilities


GENSPEED Biotech is examining the possible use of GENSPEED technology for faster COVID-19 diagnostics

 Source: OÖ Nachrichten from 28.3.2020

Upper Austrian Hightechfonds invests in GENSPEED Biotech

With the recent investment in GENSPEED Biotech GmbH, the Upper Austrian Hightechfonds has brought a promising biotech company into its portfolio. GENSPEED is currently starting with the development of a rapid test for COVID-19 from…

Read more›

GENSPEED is funded by Austrian Research Promotion Agency for development of unique COVID19 rapid test

GENSPEED develops first point of care test that allows to target both, infected and recovered patients. 


Pressrelease GENSPEED COVID19 point of care test